AIN
Dentalink: Lab SaaS

Dentalink: Lab SaaS

location_on Hong Kong ,  Hong Kong

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

Dentalink is a subscription-based SaaS laboratory ordering platform built for global use and scalable to any regional market.

Highlights

  • First SaaS platform designed for outsourced dental laboratory workflows
  • €10,000 monthly revenue target by 12/2025 with 30 resellers at break-even
  • 10+ years industry expertise solving real pain points competitors ignore
  • Global expansion via Hong Kong targeting Chinese manufacturing hub
  • Exit strategy: acquisition/IPO within 3-4 years at >€10M valuation

Overview

Target A$900,000
Minimum A$100,000
Investment Raised A$0
Previous Rounds A$0
Stage Pre-Startup/R&D
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects